SCHEMBL24072349

SCHEMBL24072349

CCCCNc1ccc(C(=O)Nc2ncc(N=O)s2)c(C(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F2R P25116 2/20 0.39
▸ CDK2 P24941 3/20 0.36
▸ PLK1 P53350 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ CCNE1 P24864 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ AXL P30530 3/20 0.34
▸ TYRO3 Q06418 3/20 0.34
▸ MERTK Q12866 3/20 0.34
▸ IRAK4 Q9NWZ3 1/20 0.34
▸ PSEN1 P49768 1/20 0.34
▸ PSEN2 P49810 1/20 0.34
▸ APH1B Q8WW43 1/20 0.34
▸ NCSTN Q92542 1/20 0.34
▸ APH1A Q96BI3 1/20 0.34
▸ PSENEN Q9NZ42 1/20 0.34
▸ RRM2 P31350 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ PNLIP P16233 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27136866 0.88 PLK1 (0.41) F2RPLK1ALDH1A1AXLTYRO3
SCHEMBL24074042 0.86 ALDH1A1 (0.42) F2RCDK2PLK1ALDH1A1AXL
SCHEMBL24073964 0.85 ALDH1A1 (0.39) F2RALDH1A1USP2PNLIPSMN1; SMN2
SCHEMBL24074000 0.84 F2R (0.41) F2RCDK2PLK1ALDH1A1CCNE1
SCHEMBL24072333 0.83 F2R (0.42) F2RCDK2PLK1ALDH1A1CCNE1
SCHEMBL24073644 0.83 F2R (0.40) F2RPLK1PNLIPCRBN
SCHEMBL27135957 0.83 STAT3 (0.53) ALDH1A1ADORA2ASMN1; SMN2
SCHEMBL24074052 0.82 MEN1 (0.42) F2RALDH1A1ADORA2APNLIPSMN1; SMN2
SCHEMBL24074046 0.80 PLK1 (0.41) F2RPLK1PNLIPCRBN
SCHEMBL24072305 0.79 CCNE1 (0.49) CDK2ALDH1A1CCNE1CDK5USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 — — US disclosed
WO-2021239117-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI) , INC. (CN) 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 F2R 1930/4885CDK2 500/4885PLK1 1263/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 F2R 1930/4885CDK2 500/4885PLK1 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback